Add to my selection

VIMIZIM (elosulfase alpha), enzyme recombinante

Medicine - Posted on Jun 29 2023

Active substance (DCI)

élosulfase alfa

history (2)

6/21/23

VIMIZIM (elosulfase alfa) - Mucopolysaccharidosis type IVA (Morquio A Syndrome)

-

CAV :
54321

icône flèche
10/1/14

VIMIZIM (elosulfase alfa), recombinant enzyme

Moderate clinical added value in mucopolysaccharidosis, type IV A (Morquio A Syndrome) VIMIZIM has a Marketing Authorisation...

CAV :
54321

icône flèche

Technical information

ATC code

A16AB12

Manufacturer

BIOMARIN INTERNATIONAL LIMITED

Presentation

VIMIZIM 1 mg/ml, solution à diluer pour perfusion (code CIS : 61673965)
1 flacon en verre de 5 ml (CIP : 34009 586 727 0 5)

All our publications

Congenital, genetic and rare diseases

Metabolic diseases